Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets

Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets

Abstract Cytokines play crucial roles in orchestrating complex multicellular interactions between pancreatic β cells and immune cells in the development of type 1 diabetes (T1D) and are thus potential immunotherapeutic targets for this disorder. Cytokines that can induce regulatory functions—for exa...

Full description

Bibliographic Details
Main Authors:	Jingli Lu, Jiyun Liu, Lulu Li, Yan Lan, Yan Liang
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Clinical & Translational Immunology
Subjects:	cytokine immunotherapy type 1 diabetes β‐cell destruction
Online Access:	https://doi.org/10.1002/cti2.1122

Similar Items

The level of circulating cytokines and chemokines in the preclinical and early clinical stages of development of type 1A diabetes mellitus
by: Konstantin Petrovich Zak, et al.
Published: (2010-10-01)

New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27
by: Fatemeh Zamani, et al.
Published: (2015-12-01)

Dendritic Cell Stimulation by IFN-β Alters T Cell Function via Modulation of Cytokine Secretion in Diabetes Type 1
by: Saeid Abediankenari, et al.
Published: (2009-10-01)

The Immunotherapeutic Effects of Pentoxifylline in Type 1 Diabetic Mice and its Effects on Expressions of Peroxisome proliferator-activated receptor gamma (PPARγ) gene
by: F Malekifar, et al.
Published: (2015-05-01)

Evaluation of cytokines in type 1 diabetes patients with and without retinopathy
by: Jéssica F. Cardoso, et al.

Cytokine profile and lymphocyte subsets in type 2 diabetes
by: C.O. Francisco, et al.
Published: (2016-01-01)

Increased Serum Cytokines Levels in Type 2 Diabetes Mellitus Associated with Arterial Hypertension: A Link to Cardio-Metabolic Risk Factors
by: Marwan Al-Nimer, et al.
Published: (2016-12-01)

Th1/Th2 cytokines in Type 1 diabetes: Relation to duration of disease and gender
by: Hajar Vaseghi, et al.
Published: (2016-01-01)

Diol-ginsenosides from Korean Red Ginseng delay the development of type 1 diabetes in diabetes-prone biobreeding rats
by: Chung Ju, et al.
Published: (2020-07-01)

Type 2 diabetes mellitus increases inflammation in periodontitis by promoting CD4+ T helper cell cytokine production
by: Kim, Sophia Hyun
Published: (2016)

Evaluation of the natural killer cytotoxicity and the levels of cytokines in rats with type I diabetes mellitus
by: Isil Fidan, et al.
Published: (2005-12-01)

Correlation of Wnt/β-catenin pathway changes with cytokines and apoptosis genes in diabetic foot wound
by: Xiao-Yu Lv, et al.
Published: (2019-08-01)

Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs
by: William Wheat, et al.
Published: (2019-09-01)

Means, Motive, and Opportunity: Do Non-Islet-Reactive Infiltrating T Cells Contribute to Autoimmunity in Type 1 Diabetes?
by: Teresa Rodriguez-Calvo, et al.
Published: (2021-06-01)

Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease
by: V I Konenkov, et al.
Published: (2015-06-01)

Systemic TNFα correlates with residual β-cell function in children and adolescents newly diagnosed with type 1 diabetes
by: Anne Julie Overgaard, et al.
Published: (2020-09-01)

COMBINATIONS OF CYTOKINE AND MATRIX METALLOPROTEINASE GENES ASSOCIATED WITH RETINOPATHY IN TYPE 2 DIABETIC WOMEN
by: V. I. Konenkov, et al.
Published: (2015-12-01)

Combinations of cytokine and matrix metalloproteinase genes associated with retinopathy in type 2 diabetic women
by: V.I. Konenkov,, et al.
Published: (2013-04-01)

Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes
by: Jingli Lu, et al.
Published: (2019-05-01)

Inhibition of inflammatory cytokines - potential new treatment for diabetic nephropathy
by: Correia, Amanda
Published: (2016)

Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells
by: Zhu Wang, et al.
Published: (2020-03-01)

Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer’s mouse model
by: Sitara B. Sankar, et al.
Published: (2020-01-01)

Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance
by: Weiyi Cai, et al.
Published: (2017-11-01)

Study of the NLRP3 inflammasome component genes and downstream cytokines in patients with type 2 diabetes mellitus with carotid atherosclerosis
by: Junli Lee, et al.
Published: (2017-11-01)

TREX1 as a Novel Immunotherapeutic Target
by: Wayne O. Hemphill, et al.
Published: (2021-04-01)

TH1 and TH2 cytokines dataset in insulin users with diabetes mellitus and newly diagnosed breast cancer
by: Zachary A.P. Wintrob, et al.
Published: (2017-04-01)

T-helper Cell Type-1 Transcription Factor T-Bet Is Down-regulated in Type 1 Diabetes
by: Hajar Vaseghi, et al.
Published: (2016-10-01)

The content of pro-inflammatory cytokines IL-1β, IL-6, IL-17A and TNFα in the blood of patients with type 2 diabetes after therapy with metformin
by: K. P. Zak, et al.
Published: (2020-12-01)

New Insights Into the Role of Autoreactive CD8 T Cells and Cytokines in Human Type 1 Diabetes
by: Christine Bender, et al.
Published: (2021-01-01)

Suppressors of cytokine signaling in sickness and in health of pancreatic β-cells
by: Cheng eYe, et al.
Published: (2016-05-01)

Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses
by: Ali A. Rabaan, et al.
Published: (2021-05-01)

Cytokines in Cancer Immunotherapy
by: Sylvia Lee, et al.
Published: (2011-10-01)

Immunotherapy Strategies for the Prevention and Treatment of Distinct Stages of Type 1 Diabetes: An Overview
by: Novella Rapini, et al.
Published: (2020-03-01)

Combinations of polymorphisms in the regulatory regions of cytokine genes are associated with diabetic retinopathy in type 2 diabetic patients
by: V. I. Konenkov, et al.
Published: (2018-01-01)

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
by: Ken Coppieters, et al.
Published: (2018-10-01)

Dendritic Cell Stimulation by IFN-β Alters T Cell Function via Modulation of Cytokine Secretion in Diabetes Type 1
by: Abediankenari Saeid, et al.
Published: (2009-10-01)

Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies
by: Vassilis Genoud, et al.
Published: (2021-03-01)

Current Immunotherapeutic Strategies for the Treatment of Glioblastoma
by: Mark Dapash, et al.
Published: (2021-09-01)

Kynurenine, Tetrahydrobiopterin, and Cytokine Inflammatory Biomarkers in Individuals Affected by Diabetic Neuropathic Pain
by: Ananda Staats Pires, et al.
Published: (2020-08-01)

Differential Expression of Inflammatory Markers in Hypoglycemia Unawareness Associated with Type 1 Diabetes: A Case Report
by: Yousef Al Zoubi, et al.
Published: (2021-12-01)